Sio Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1M Buy
+193,500
New +$11.1M 1.85% 22
2019
Q1
Sell
-50,000
Closed -$2.6M 75
2018
Q4
$2.6M Buy
+50,000
New +$2.69M 0.95% 42
2016
Q3
Sell
-37,419
Closed -$2.75M 37
2016
Q2
$2.75M Buy
+37,419
New +$2.64M 1.41% 25
2016
Q1
Sell
-53,862
Closed -$3.71M 46
2015
Q4
$3.71M Sell
53,862
-28,872
-35% -$1.91M 1.64% 20
2015
Q3
$4.9M Buy
+82,734
New +$5.25M 3.36% 16

Other funds holding BMY

Sio Capital Management's BMY Position: Q2 2026 in Review

Sio Capital Management opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 193,500 shares worth $11.1M. The stake represents 1.85% of the portfolio and ranks #22 among its holdings. This is a return to the name: Sio Capital Management previously reported a position in BMY as recently as Q4 2018.

Sio Capital Management first reported a position in BMY in Q3 2015 and has held it in 5 quarters since. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Sio Capital Management held 193,500 shares of Bristol-Myers Squibb worth $11.1M as of Q2 2026.
  • Bristol-Myers Squibb was a new Sio Capital Management position in Q2 2026.
  • Bristol-Myers Squibb made up 1.85% of Sio Capital Management's portfolio in Q2 2026, its #22 holding.
  • Sio Capital Management first reported a position in Bristol-Myers Squibb in Q3 2015 and has held it in 5 quarters since.
  • 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.